Multimorbidity, polypharmacy, referrals, and adverse drug events: Are we doing things well?

British Journal of General Practice

Volumn 62, Issue 605, 2012, Pages

  Calderón Larrañaga, Amaia ^a   Poblador Plou, Beatriz ^a   González Rubio, Francisca ^b   Gimeno Feliu, Luis Andrés ^c   Abad Díez, José María ^d   Prados Torres, Alexandra ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

Adverse drug event; Healthcare system, national; Multimorbidity, multiple; Polypharmacy; Referral, hospital

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; DRUG SAFETY; FEMALE; HEALTH CARE SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMORBIDITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PATIENT REFERRAL; POLYPHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYPHARMACY; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84870709395     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X659295     Document Type: Article

References (35)

1. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011; 10(4): 430-439.
2. Prados-Torres A, Poblador-Plou B, Calderon-Larranaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One 2012; 7(2): e32190.
3. van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51(5): 367-375. (Pubitemid 28223302)
4. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351(27): 2870-2874.
5. Starfield B, Lemke KW, Herbert R, et al. Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med 2005; 3(3): 215-222. (Pubitemid 40806714)
6. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348(16): 1556-1564. (Pubitemid 36437933)
7. Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005; 53(9): 1518-1523. (Pubitemid 41602441)
8. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007; 5(1): 31-39. (Pubitemid 47099502)
9. The European study of referrals from primary to secondary care. Concerned Action Committee of Health Services Research for the European Community. Occas Pap R Coll Gen Pract 1992; (56): 1-75.
10. Lamberts H, Wood M. ICPC: International classification of primary care. Oxford: Oxford University Press, 1987.
11. Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res 1991; 26(1): 53-74.
12. Johns Hopkins Bloomberg School of Public Health. The Johns Hopkins ACG® System. Reference manual, version 8.2. Baltimore: The Johns Hopkins University, 2008. http://www.ensolution.se/upl/files/14429.pdf (accessed 19 Oct 2012).
13. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50(12): 1962-1968. (Pubitemid 35462441)
14. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52(8): 1349-1354. (Pubitemid 39038210)
15. Evans RS, Lloyd JF, Stoddard GJ, et al. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 2005; 39(7-8): 1161-1168. (Pubitemid 40943163)
16. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57(2): 121-126. (Pubitemid 38223523)
17. Tierney WM. Adverse outpatient drug events - a problem and an opportunity. N Engl J Med 2003; 348(16): 1587-1589. (Pubitemid 36437936)
18. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-1205. (Pubitemid 28193431)
19. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-ofillness model. Arch Intern Med 1995; 155(18): 1949-1956.
20. Ministerio de Sanidad y Consumo. Estudio APEAS. Estudio sobre la seguridad de los pacientes en atención primaria de salud. Madrid: Ministerio de Sanidad y Consumo, 2008.
21. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385-396.
22. Gonzalez-Rubio F, Calderon-Larranaga A, Poblador-Plou B, et al. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study. Pharmacoepidemiol Drug Saf 2011; 20(12): 1287-1294.
23. Lim EC, Seet RC. Too many cooks spoil the broth. Acad Med 2007; 82(5): 474.
24. Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med 2006; 4(2): 101-103.
25. Perez GS, Millas RJ, Lopez Zuniga MC, et al. [Analysis of the induced prescription in a primary care region]. Rev Calid Asist 2010; 25(6): 321-326.
26. Ruiz D, V, Unzueta ZL, Fernandez UJ, et al. [Induced prescription in primary health care in area Bilbao]. Aten Primaria 2002; 29(7): 414-420.
27. Delgado SO, Nicolas PJ, Martinez L, et al. [Reconciliation errors at admission and departure in old and polymedicated patients. Prospective, multicentre randomised study]. Med Clin (Barc) 2009; 133(19): 741-744.
28. Sanfelix-Gimeno G, Peiro S, Meneu R. [Pharmaceutical prescription in primary care. SESPAS report 2012]. Gac Sanit 2012; 26(suppl 1): 41-45.
29. Forster AJ, Jennings A, Chow C, et al. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc 2012; 19(1): 31-38.
30. Rozich JD, Howard RJ, Justeson JM, et al. Standardization as a mechanism to improve safety in health care. Jt Comm J Qual Saf 2004; 30(1): 5-14.
31. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116(6): 394-401. (Pubitemid 38299484)
32. Starfield B. New paradigms for quality in primary care. Br J Gen Pract 2001; 51(465): 303-309. (Pubitemid 32293737)
33. Delgado SO, Anoz JL, Serrano FA, Nicolas PJ. [Conciliation in medication]. Med Clin (Barc) 2007; 129(9): 343-348.
34. Fortin M, Dionne J, Pinho G, et al. Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med 2006; 4(2): 104-108.
35. Starfield B, Lemke KW, Bernhardt T, et al. Comorbidity: implications for the importance of primary care in 'case' management. Ann Fam Med 2003; 1(1): 8-14.